Artículos del autor

solaci

Other

When and How Could Dexamethasone Be Useful in a COVID-19 Infection?

More details have emerged on the group of COVID-19 patients who received dexamethasone in the RECOVERY trial. These...
solaci -
Institutional News

Webinar SOLACI Research | Left Main Coronary Disease Controversy After EXCEL 5 Years

Watch again our Webinar on "Left Main Coronary Disease Controversy After EXCEL 5 Years” on our Youtube...
solaci -
Institutional News

SOLACI Research Survey | Reasons NOT to Conduct TAVR in Latin America

The Latin American Society of Interventional Cardiology, through the SOLACI Research Department, is conducting a survey to...
solaci -
Acute coronary syndromes

Long Term Changes ACS Revascularization

Long term outcomes support complete revascularization in multivessel patients undergoing acute coronary syndrome (ACS). This large contemporary registry...
solaci -
Coronary disease

Rapid Drop of Antibodies in Mild COVID-19 patients

A fast drop in COVID-19 antibodies in mild patients triggers the alarm for protection against the new...
solaci -
Other

COVID-19 PE: Nontraditional Risk Factors?

Risk factors for pulmonary embolism (PE) among patients with the new coronavirus are different from those traditionally...
solaci -
Institutional News

2° ProEducar Educational Meeting – Aortic Valve Implantation. Session II

Watch again our "2nd ProEducar Educational Meeting on "Transcatheter Aortic Valve Implantation” on our Youtube account.  We are...
solaci -
Structural heart disease

Valve in Valve Presents Better Evolution than re-SARV

Courtesy of Dr. Carlos Fava. Surgical aortic valve replacement with bioprosthesis has proved its benefits, but it fails...
solaci -